January 11, 2021 – Imagia, today announced that it is participating in Biotech Showcase™ 2021, and providing an on-demand company presentation. This year registered attendees to Biotech Showcase can access recorded company presentations beginning November 30th – SIX weeks prior to the actual event. 24x7 on-demand access allows attendees to view presentations at their convenience, avoiding conflicts with busy meeting schedules during the main event week.
Geralyn Ochab, Chief Executive Officer will be presenting Imagia at Biotech Showcase Digital.
Imagia is on a Mission to build the world’s largest AI collaboration platform that enables the transformation of healthcare expertise into products that improve and personalize the patient journey. An AI healthcare company, Imagia develops digital medical innovations to improve the health of cancer patients and those afflicted with other high-burden diseases. Through its collaborative ecosystem, Imagia EVIDENSTM enables hospitals, medical device manufacturers, pharmaceutical companies, and diagnostic companies around the world to access and utilize healthcare data while preserving data privacy. This technology is currently being deployed as part of the $200M pan-canadian government supported initiative, co-lead by The Terry Fox Research Institute and Imagia. (dhdp.ca)
‘’As Imagia grows its network of clinicians using the platform to cohort, structure and enrich data,’’ says Geralyn Ochab, CEO of Imagia, ‘’ it will unveil more clinical insights and medical discoveries will scale, allowing for several commercialization of these findings to pharmaceuticals, medical device companies and clinical service providers. The industry will then integrate these findings to their business models and leverage these medical breakthroughs.’’
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
“We are delighted that Imagia will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
ABOUT BIOTECH SHOWCASE
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 13th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
Imagia, an AI healthcare company, develops digital medical innovations that improve the health of cancer patients and those afflicted with other high-burden diseases. Through its collaborative ecosystem, Imagia EVIDENS(TM) enables hospitals, medical device manufacturers, pharmaceutical companies, and diagnostic companies around the world to access and utilize healthcare data while preserving data privacy. The company’s head office is located in Montreal, Canada. imagia.com
Follow Imagia on Twitter at @imagia_ai and Biotech Showcase at @EBDGroup and @Demy_Colton and tag your posts with #BiotechShowcase.